HilaMilo Rasouly Columbia UniversityUnited States

Hila Milo Rasouly is an Assistant Professor of Medical Sciences in the Department of Medicine and the Associate Director of Education of the Center for Precision Medicine and Genomics at Columbia University. She has a master in Genetic Counseling from the Hebrew University in Jerusalem, Israel and a Ph.D. in Genetics and Genomics from Boston University, MA. Her research interests are focused on the implementation of genomics in internal medicine.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? Fatiu AbiolaArogundade Chairperson fatiu3@yahoo.comObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria Nigeria FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comUniversidade Federal do Rio Grande do SulBrazil OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduDuke University School of MedicineUnited States Ethical Aspects of Race-based Genetic Testing AnaIltis Speaker iltisas@wfu.eduWake Forest UniversityUnited States Contribution of ApoL1 Risk Genotype to HIVAN SaraladeviNaicker Speaker University of the Witwatersrand South Africa Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa DwomoaAdu Speaker dwoms@blueyonder.co.ukUniversity of Ghana Medical SchoolGhana Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials OgoEgbuna Speaker ogo_egbuna@vrtx.comVertex Pharmaceuticals IncUnited States Q and A Hall C2
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria Hall A
12:15 p.m. 1:15 p.m.	Hot Debate: Should a Low Protein Diet (+/- Ketoanalogue Supplementation) Be Part of Advanced CKD Management? CarlaAvesani Chairperson carla.avesani@ki.seKarolinska InstituteSweden SahirKalim Chairperson skalim@mgh.harvard.eduHarvard Medical School/ Massachusetts General Hospital United States Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - PROS ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - CONS SwapnilHiremath Speaker University of OttawaCanada Hall A
3 p.m. 4 p.m.	Kidney Health for All - Advancing Equitable Access to Care and Optimal Medication Practice: WKD Session DinaAbdellatif Chairperson Cairo University HospitalEgypt VassiliosLiakopoulos Chairperson liakopul@otenet.gr2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thesalloniki, GreeceGreece Building Bridges to Reduce Fragmentation of Kidney Care RicardoCorrea Rotter Speaker correarotter@gmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico Transforming Kidney Care Through Equitable Breakthrough Therapies KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States Closing the Gaps: Implementing Best Practices for CKD Care Worldwide ValerieLuyckx Speaker valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Patient's Perspective on Gaps in Care MariaSeijas Speaker Mseijas@ifc.orgCFAArgentina Q and A Hall C1
4:30 p.m. 5:30 p.m.	Policy and Advocacy Approaches Lori-AnnFisher Chairperson lori2k15@gmail.comUniversity of the West Indies, MonaJamaica MarcelloTonelli Chairperson cello@ucalgary.caSenior Associate Dean (Clinical Research), CummingCanada Universal Health Coverage for Kidney Diseases: Feasibility, Barriers, and Opportunities for Improving Global Kidney Health VivekanandJha Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia The Role of Kidney Health Advocacy Organizations in Reducing the Global Burden of Kidney Diseases ValerieLuyckx Speaker valerie.luyckx@uzh.chUniversity of ZurichSwitzerland A Case for National Prevention Programs to Manage CKD IkechiOkpechi Speaker University of AlbertaCanada Q and A Hall A

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Genetics and Genomics of Rare Kidney Disease: ISN-Indian SN Joint Session PaulaCoccia Chairperson paula.coccia@hospitalitaliano.org.arHospital Italianod de Buenos Aires Argentina Shyam BihariBansal Chairperson India Genomics of Rare Genetic Diseases: Experiences From India VinodScaria Speaker vinods@igib.inVishwanath Cancer Care Foundation & Indian Institute of Technology KanpurIndia On the Way to Translate GWAS into Kidney Disease Mechanisms KrzysztofKiryluk Speaker Columbia UniversityUnited States X-linked Kidney Disorders in Women MichelleRheault Speaker rheau002@umn.eduUniversity of MinnesotaUnited States Prenatal/Preimplantation Genetic Diagnosis and Genetic Counseling for Genetic Kidney Disorders NineKnoers Speaker v.v.a.m.knoers@umcg.nlDepartment of Genetics, University Medical Centre Groningen, Groningen, The NetherlandsNetherlands Q and A Hall E
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comhttps://research.ibm.com/Israel Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? MartaAdragna Chairperson marta.adragna@gmail.comArgentina MoumitaBarua Chairperson moumita.barua@uhn.caCanada Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? - All Patients AlbertienVan Eerde Speaker Department of Genetics, UMC Utrecht, The NetherlandsNetherlands Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? High-risk Populations Only HilaMilo Rasouly Speaker Hila.MiloRasouly@columbia.eduColumbia UniversityUnited States Hall A
12:45 p.m. 1:30 p.m.	Keys to success to be on top of what is published in nephrology (ISN-ACT) AndreaViecelli Spotlight Speaker andrea.viecelli@health.qld.gov.auUniversity of QueenslandAustralia Augusto CesarSoares dos Santos Junior Spotlight Speaker acssjunior@hotmail.comHospital das Clinicas, UFMG; Fac Ciências MedicasBrazil BrendanSmyth Spotlight Speaker brendan.smyth@sydney.edu.auAustralia DavidWheeler Spotlight Speaker University College LondonUnited Kingdom MegJardine Spotlight Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	Disparities in the Care of People Living with Kidney Failure in Latin America AdeeraLevin Chairperson University of British Columbia and Providence Health CareCanada AminuBello Chairperson aminu1@ualberta.caUniversity of AlbertaCanada Global Assessment of Kidney Care Capacity and Policy and Perspectives on Enhancing Global Kidney Care-Findings From the ISN-GKHA AminuBello Speaker aminu1@ualberta.caUniversity of AlbertaCanada State of CKD Care for Kidney Disease in Latin American Region Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico Variability in The Burden, Management and Outcomes of Kidney Failure Between Children and Adults in Latin America MarinaWainstein Speaker marinawainstein@outlook.comUniversity of QueenslandAustralia Q and A Hall C1
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom Patients Subphenotyping: The Example of Diabetic Kidney Disease John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease LauraMariani Speaker University of MichiganUnited States Targeted Approaches in Clinical Trial Design HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

12:30 p.m. 1:30 p.m.	Rare and Orphan Diseases AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States RobertaFenoglio Chairperson roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina Alport Spectrum Disorders (Genetics) MoumitaBarua Speaker moumita.barua@uhn.caCanada Genetics of Nephrotic Syndrome SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduColumbia UniversityUnited States Lupus Nephritis Transcriptomics Across Time and Space AnaMalvar Speaker avmperrin@yahoo.com.arHospotal Fernandez, Organizacion Medica de InvestigacionArgentina Q and A Hall E

Time

Session

12:30 p.m.

1:30 p.m.

Rare and Orphan Diseases

AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States

RobertaFenoglio Chairperson roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly

VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina

Alport Spectrum Disorders (Genetics)

MoumitaBarua Speaker moumita.barua@uhn.caCanada
Genetics of Nephrotic Syndrome

SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduColumbia UniversityUnited States
Lupus Nephritis Transcriptomics Across Time and Space

AnaMalvar Speaker avmperrin@yahoo.com.arHospotal Fernandez, Organizacion Medica de InvestigacionArgentina
Q and A

Hall E

Pre-Congress - Saturday April 13, 2024

Time	Session

4:30 p.m. 6 p.m.	WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina) ISN President's Address MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Tribute to Stewart Cameron Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina JorgeRico Speaker jorgericof@yahoo.comColombia MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina Welcome by Minister of Health for Buenos Aries Dr Fern Welcome by SPWG Chair Alessia Fornoni AlessiaFornoni Speaker United States The Origin of the Universe DanielDe Florian Speaker deflo@unsam.edu.arUniversidad Nacional de San MartinArgentina Acceptance Speech: Hamburger Award AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada Hall A
6:45 p.m. 7:15 p.m.	Building Renal Registry Capacity: Introducing ISN EtienneNtabanganyimana Spotlight Speaker ntet07@yahoo.frRwanda MariaPippias Spotlight Speaker University of BristolUnited Kingdom FergusCaskey Spotlight Chairperson University of Bristol, UKUnited Kingdom MariaGonzalez Spotlight Chairperson registro@slanh.netSLANHUruguay Spotlight Stage 1 (exhibition hall)